Benzoyl Peroxide/AE AND Clindamycin/AE - Search Results

Year	Number of Results
1997	1
2001	1
2002	1
2005	1
2006	3
2007	2
2008	4
2009	12
2010	5
2011	2
2012	10
2013	5
2014	2
2015	4
2016	1
2017	2
2018	4
2021	1
2023	0

1

Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.

Aschoff R, Möller S, Haase R, Kuske M. Aschoff R, et al. J Drugs Dermatol. 2021 Mar 1;20(3):295-301. doi: 10.36849/JDD.2021.5641. J Drugs Dermatol. 2021. PMID: 33683070 Clinical Trial.

2

Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.

Kircik LH. Kircik LH. J Drugs Dermatol. 2017 Jun 1;16(6):543-546. J Drugs Dermatol. 2017. PMID: 28686771 Clinical Trial.

3

The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.

Bucks D, Sarpotdar P, Yu K, Angel A, Del Rosso J. Bucks D, et al. J Drugs Dermatol. 2009 Jul;8(7):634-8. J Drugs Dermatol. 2009. PMID: 19588639 Clinical Trial.

4

Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.

Amar L, Kircik LH. Amar L, et al. J Drugs Dermatol. 2018 Oct 1;17(10):1107-1112. J Drugs Dermatol. 2018. PMID: 30365592 Clinical Trial.

5

Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.

Stein Gold L. Stein Gold L. J Drugs Dermatol. 2015 Sep;14(9):969-74. J Drugs Dermatol. 2015. PMID: 26355615 Clinical Trial.

6

Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.

Callender VD. Callender VD. J Drugs Dermatol. 2012 May;11(5):643-8. J Drugs Dermatol. 2012. PMID: 22527435 Clinical Trial.

7

Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.

Harper JC. Harper JC. J Drugs Dermatol. 2012 Dec;11(12):1440-5. J Drugs Dermatol. 2012. PMID: 23377514 Clinical Trial.

8

Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.

Eichenfield LF, Krakowski AC. Eichenfield LF, et al. J Drugs Dermatol. 2012 Jul;11(7):818-24. J Drugs Dermatol. 2012. PMID: 22777222 Clinical Trial.

9

[Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].

Fluhr JW, Degitz K. Fluhr JW, et al. J Dtsch Dermatol Ges. 2010 Mar;8 Suppl 1:S24-30. doi: 10.1111/j.1610-0387.2009.07169.x. J Dtsch Dermatol Ges. 2010. PMID: 20482689 Review. German.

10

Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.

Bowman S, Gold M, Nasir A, Vamvakias G. Bowman S, et al. J Drugs Dermatol. 2005 Sep-Oct;4(5):611-8. J Drugs Dermatol. 2005. PMID: 16167420 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results